Vault-13

Foresite Capital Management VI LLC

WEST HOLLYWOOD, CA · CIK 2013341 · 13F filing filed 2025-05-15

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$182.5m reported value -18.7% vs Q4 2024
14positions
93.6%in top 10
0 new 0 added 0 reduced 0 sold out vs Q4 2024

Holdings, Q1 2025

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 CG ONCOLOGY INC COM CGON CGON 2,221,474 $54.4m29.80% 29.80% UnchangedShares held: Q2 2024 —, Q3 2024 —, Q4 2024 2.2m, Q1 2025 2.2m
2 ALUMIS INC COM ALMS ALMS 4,202,670 $25.8m14.14% 14.14% UnchangedShares held: Q2 2024 —, Q3 2024 —, Q4 2024 4.2m, Q1 2025 4.2m
3 CENTESSA PHARMACEUTICALS PLC SPONSORED ADS SPONSORED ADS 1,253,379 $18.0m9.87% 9.87% UnchangedShares held: Q2 2024 —, Q3 2024 —, Q4 2024 1.3m, Q1 2025 1.3m
4 RAPT THERAPEUTICS INC COM COM 12,500,000 $15.2m8.35% 8.35% UnchangedShares held: Q2 2024 —, Q3 2024 —, Q4 2024 12.5m, Q1 2025 12.5m
5 AKERO THERAPEUTICS INC COM AKRO AKRO 365,000 $14.8m8.09% 8.09% UnchangedShares held: Q2 2024 —, Q3 2024 —, Q4 2024 365.0k, Q1 2025 365.0k
6 EDGEWISE THERAPEUTICS INC COM EWTX EWTX 585,000 $12.9m7.05% 7.05% UnchangedShares held: Q2 2024 —, Q3 2024 —, Q4 2024 585.0k, Q1 2025 585.0k
7 BICARA THERAPEUTICS INC COM BCAX BCAX 950,000 $12.4m6.78% 6.78% UnchangedShares held: Q2 2024 —, Q3 2024 —, Q4 2024 950.0k, Q1 2025 950.0k
8 STRUCTURE THERAPEUTICS INC SPONSORED ADS GPCR GPCR 420,000 $7.3m3.98% 3.98% UnchangedShares held: Q2 2024 —, Q3 2024 —, Q4 2024 420.0k, Q1 2025 420.0k
9 ALLOGENE THERAPEUTICS INC COM ALLO ALLO 3,448,275 $5.0m2.76% 2.76% UnchangedShares held: Q2 2024 —, Q3 2024 —, Q4 2024 3.4m, Q1 2025 3.4m
10 CORVUS PHARMACEUTICALS INC COM CRVS CRVS 1,581,233 $5.0m2.75% 2.75% UnchangedShares held: Q2 2024 —, Q3 2024 —, Q4 2024 1.6m, Q1 2025 1.6m
11 CULLINAN THERAPEUTICS INC COM CGEM CGEM 634,558 $4.8m2.63% 2.63% UnchangedShares held: Q2 2024 —, Q3 2024 —, Q4 2024 634.6k, Q1 2025 634.6k
12 KYMERA THERAPEUTICS INC COM KYMR KYMR 146,332 $4.0m2.19% 2.19% UnchangedShares held: Q2 2024 —, Q3 2024 —, Q4 2024 146.3k, Q1 2025 146.3k
13 CASI PHARMACEUTICALS INC ORD SHS CASIF CASIF 1,329,383 $2.9m1.57% 1.57% UnchangedShares held: Q2 2024 —, Q3 2024 —, Q4 2024 1.3m, Q1 2025 1.3m
14 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 1,974 $26.6k0.01% 0.01% UnchangedShares held: Q2 2024 —, Q3 2024 —, Q4 2024 2.0k, Q1 2025 2.0k